521 PREOPERATIVE BOTULINUM TOXIN TYPE A: PROPOSAL OF A NEW STRATEGY FOR GIANT HERNIA MANAGEMENT

2021 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
Edno Tales Bianchi ◽  
Rider Cedro ◽  
Camila Vilanova ◽  
Francisco Tustumi ◽  
Ricardo Abdalla ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Ct Scan ◽  
Abdominal Wall ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
New Strategy ◽  
Giant Hiatal Hernia ◽  
Giant Hernia ◽  
New Space ◽  
Abdominal Compartment

Abstract   Botulinum toxin is already in use to treat abdominal wall giant hernia. The concept is to reduce pressure e create new space in the abdominal compartiment after the surgey. We show a case that a similar aproach was used to treat giant hiatal hernia. Methods We used botulinum toxin 4 weeks prior the surgery to increase de abdominal compartment. it was checked in a ct scan. Results The surgey was performed with a hiatoplasty, fundoplication and a gastropexy. Conclusion The use of botulinum seens to be a new stragy for selected cases. Video https://www.dropbox.com/s/td7fr3a6buejqnd/Bianchi%20ET%20botox.wmv?dl=0.

scholarly journals Preoperative botulinum toxin type A: A case report of a proposed new strategy for giant hiatal hernia management

2020 ◽  
Vol 8 (12) ◽  
pp. 3412-3415
Author(s):  
Francisco Tustumi ◽  
Edno Tales Bianchi ◽  
Sérgio Szachnowicz ◽  
Rider May Cedro ◽  
Antonio Afonso Miranda Neto ◽  
...  
Keyword(s):  
Case Report ◽  
Botulinum Toxin ◽  
Hiatal Hernia ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
New Strategy ◽  
Giant Hiatal Hernia

Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management

Hernia ◽  
2014 ◽  
Vol 18 (5) ◽  
pp. 647-652 ◽  
Author(s):  
T. R. Ibarra-Hurtado ◽  
C. M. Nuño-Guzmán ◽  
A. G. Miranda-Díaz ◽  
R. Troyo-Sanromán ◽  
R. Navarro-Ibarra ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Incisional Hernia ◽  
Abdominal Wall ◽  
Open Abdomen ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Lateral Abdominal Wall

Use of Botulinum Toxin Type A Before Abdominal Wall Hernia Reconstruction

2009 ◽  
Vol 33 (12) ◽  
pp. 2553-2556 ◽  
Author(s):  
Tomas R. Ibarra-Hurtado ◽  
Carlos M. Nuño-Guzmán ◽  
Jorge E. Echeagaray-Herrera ◽  
Everardo Robles-Vélez ◽  
José de Jesús González-Jaime
Keyword(s):  
Botulinum Toxin ◽  
Abdominal Wall ◽  
Botulinum Toxin Type A ◽  
Abdominal Wall Hernia ◽  
Type A ◽  
Botulinum Toxin Type

Long-term results of botulinum toxin type A in complex abdominal wall repair and review of the literature

2020 ◽  
Vol 72 (4) ◽  
pp. 1201-1206 ◽  
Author(s):  
Vanesa Catalán-Garza ◽  
María Jesús Peña-Soria ◽  
Patricia Sáez-Carlin ◽  
Juan Jesús Cabeza-Gómez ◽  
Andrés García-Fernández ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Abdominal Wall ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Long Term Results ◽  
Review Of The Literature ◽  
Abdominal Wall Repair

scholarly journals Complex Incisional Hernia – Easy To Diagnose But What To Do After?

2021 ◽  
pp. 254
Author(s):  
Keyword(s):  
Botulinum Toxin ◽  
Abdominal Wall ◽  
Rapid Development ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Fascial Closure ◽  
Loss Of Domain ◽  
Umbilical Hernia Repair ◽  
Preoperative Progressive Pneumoperitoneum

Introduction. Loss of domain represents a defect in abdominal wall or loss of continuity of fascial closure, with more than 20% of the peritoneal cavity content under the skin in a serous sac, where the reconstruction involves additional reconstructive techniques. Clinical Case. A 63-year-old active smoker with multiple comorbidities such as COPD severe form with the need for oxygen at home (may be an absolute contraindication) and surgical history of open umbilical hernia repair with a rapid development of loss of domain hernia (2 weeks after surgery) was prepared preoperatively with Botulinum Toxin type A and Preoperative Progressive Pneumoperitoneum. Discussion. Despite comorbidities, by optimizing the abdominal wall with Botulinum Toxin type A and Preoperative Progressive Pneumoperitoneum with the intraoperative use of the Rives-Stoppa technique or posterior separation of components, Abdominal Wall Strength Score improves significantly in a short time, with quick socio-economic reintegration and low-rate of complications. Conclusions. By preoperative preparation, with augmentation techniques of the abdominal wall, thus, even the barriers given by comorbidities (absolute contraindications) are overcame, with low postoperative risks, offering the patient a normal quality of life.

Sign in / Sign up

Export Citation Format

Share Document